Invention Grant
- Patent Title: Determining tumor origin
-
Application No.: US14810323Application Date: 2015-07-27
-
Publication No.: US09670553B2Publication Date: 2017-06-06
- Inventor: Mark Erlander , Xiao-Jun Ma
- Applicant: bioTheranostics, Inc.
- Applicant Address: US CA San Diego
- Assignee: bioTheranostics, Inc.
- Current Assignee: bioTheranostics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
The disclosure provides methods for the use of gene expression measurements to classify or identify among 54 cancer types in samples obtained from a subject in a clinical setting, such as in cases of formalin fixed, paraffin embedded (FFPE) samples.
Public/Granted literature
- US20150329921A1 DETERMINING TUMOR ORIGIN Public/Granted day:2015-11-19
Information query
